PROCEPT BioRobotics (PRCT) - 2023 Q4 - Earnings Call Presentation
PROCEPT BioRobotics (PRCT)2024-02-28 02:1644 2024 Financial Guidance Actual 2023 Guidance FY241 Revenue : OPEX Growth Ratio 1.5x ~1.9x Total Revenue ($ Mil) Non-GAAP Reconciliations RECONCILIATION OF 2024 GAAP NET LOSS TO ADJUSTED EBITDA Guidance (in thousands) References 3. WATER U.S. pivotal trial 2014, Ortman, An Aging Nation: The Older Population in the United States Vuichoud, C, Loughlin, K. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015 Oct;22 Suppl 1:1-6. Vuichoud, C, Loughlin, K. Benign prostatic hype ...